LAG3 and neoplasm: CD8 positivity was shared by early pre-dysfunctional TSC22D3+37, dysfunctional LAG3+ tumor-infiltrating lymphocytes (TILs)38 but decreased in the NKG7+ cytotoxic effector CD839 population40.